NZ512332A - Potassium channel interactors and uses therefor - Google Patents

Potassium channel interactors and uses therefor

Info

Publication number
NZ512332A
NZ512332A NZ512332A NZ51233299A NZ512332A NZ 512332 A NZ512332 A NZ 512332A NZ 512332 A NZ512332 A NZ 512332A NZ 51233299 A NZ51233299 A NZ 51233299A NZ 512332 A NZ512332 A NZ 512332A
Authority
NZ
New Zealand
Prior art keywords
potassium channel
uses therefor
channel interactors
interactors
pcip
Prior art date
Application number
NZ512332A
Other languages
English (en)
Inventor
Wenqian An
Kenneth Rhodes
Maria Betty
Huai-Ping Ling
Original Assignee
Wyeth Corp
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Application filed by Wyeth Corp, Millennium Pharm Inc filed Critical Wyeth Corp
Publication of NZ512332A publication Critical patent/NZ512332A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ512332A 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor NZ512332A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US11003398P 1998-11-25 1998-11-25
US11027798P 1998-11-30 1998-11-30
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor
PCT/US1999/027428 WO2000031133A2 (fr) 1998-11-20 1999-11-19 Proteines d'interaction de canaux potassiques (pcip) et procedes de leur utilisation

Publications (1)

Publication Number Publication Date
NZ512332A true NZ512332A (en) 2004-02-27

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ512332A NZ512332A (en) 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor

Country Status (12)

Country Link
EP (1) EP1131349A2 (fr)
JP (1) JP2002530104A (fr)
CN (1) CN1346368A (fr)
AU (1) AU775713B2 (fr)
BR (1) BR9915513A (fr)
CA (1) CA2351365A1 (fr)
CZ (1) CZ20011764A3 (fr)
IL (1) IL143148A0 (fr)
MX (1) MXPA01004903A (fr)
NO (1) NO20012471L (fr)
NZ (1) NZ512332A (fr)
WO (1) WO2000031133A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
BR0114383A (pt) * 2000-09-27 2005-04-12 Millennium Pharm Inc Interatuadores de canais de potássio e aplicações dos mesmos
EP2353014A2 (fr) * 2008-11-06 2011-08-10 Basf Se Test de criblage ea pour insecticides
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4758997A (en) * 1996-10-17 1998-05-11 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
CN1346368A (zh) 2002-04-24
MXPA01004903A (es) 2003-03-10
IL143148A0 (en) 2002-04-21
NO20012471L (no) 2001-07-18
EP1131349A2 (fr) 2001-09-12
WO2000031133A2 (fr) 2000-06-02
WO2000031133A3 (fr) 2000-10-05
JP2002530104A (ja) 2002-09-17
CA2351365A1 (fr) 2000-06-02
BR9915513A (pt) 2002-02-05
NO20012471D0 (no) 2001-05-18
AU775713B2 (en) 2004-08-12
CZ20011764A3 (cs) 2002-01-16
AU1479700A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
HK1158696A1 (en) Antagonistic selective binding agents of osteoprotegerin binding protein
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
ATE544776T1 (de) Chimäre dna-bindeproteine
AU4981101A (en) Subtilisin variants
CY1112101T1 (el) Νευροτροφικοι παραγοντες
AU2001294541A1 (en) Mammalian genes; related reagents and methods
NO2011003I2 (fr)
WO2003050243A3 (fr) Nouveaux genes, nouvelles compositions, nouveaux kits et nouveaux procedes d'identification, d'evaluation, de prevention et de therapie du cancer du colon
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO1996031603A3 (fr) Procedes et compositions pour reguler le niveau de la proteine 'fadd'
DK1082423T3 (da) Cyclin E2-gener og -proteiner
NZ512332A (en) Potassium channel interactors and uses therefor
DE69739346D1 (de) Gereinigtes sr-p70 protein
WO2002026929A3 (fr) Proteine moteur kini-3 et methodes d'utilisation associees
WO2001066752A3 (fr) Genes specifiques de la reproduction
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
WO2001096593A3 (fr) Nouvelles proteines motrices et procedes d'utilisation de ces proteines
WO2002012541A3 (fr) Nouvelles proteines moteurs et leurs procedes d'utilisation
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
ES2178203T3 (es) Metodos y reactivos para modular la apoptosis.
DE69827808D1 (de) Protease-ähnliches protein
WO2001098314A3 (fr) Proteines motrices et modalites d'utilisation
WO2003046125A3 (fr) Molecules d'acides nucleiques hin-2, proteines, anticorps, homologues et recepteurs associes et utilisations
WO2003048320A3 (fr) Nouvelle proteine moteur de p. falciparum et methodes d'utilisation de cette derniere

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)